October 6, 2020

06 Oct 2020 | All | Sandoz | Onco'Zine reports a new study released by the American Society of Clinical Oncology Quality Care Symposium indicates that Sandoz's Zarxio® (biosimilar filgrastim) is not only safe and effective, but is cost effective in treating chemotherap...

Please reload

Biosimilars bulletin 

November 9, 2020

Please reload

Search by tags